Cargando…
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
Jan Svoboda studied aspects of viral latency, in particular with respect to disease induction by avian RNA tumor viruses, which were later renamed as part of the extended retrovirus family. The course of retroviral pathogenesis is intrinsically linked to their unique property of integrating the DNA...
Autores principales: | Darcis, Gilles, Das, Atze T., Berkhout, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923451/ https://www.ncbi.nlm.nih.gov/pubmed/29596334 http://dx.doi.org/10.3390/v10040157 |
Ejemplares similares
-
The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
por: Darcis, Gilles, et al.
Publicado: (2019) -
Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019) -
Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs
por: Darcis, Gilles, et al.
Publicado: (2020) -
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
por: Wang, Gang, et al.
Publicado: (2016) -
CRISPR/Cas9: a double-edged sword when used to combat HIV infection
por: Liang, Chen, et al.
Publicado: (2016)